Literature DB >> 23755966

Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.

Nisha K Duggal1, Wenqing Fu, Joshua M Akey, Michael Emerman.   

Abstract

There are seven members of the APOBEC3 family in humans (APOBEC3A through APOBEC3H) that have antiviral activity against retroviruses and/or retroelements. To determine whether variants in APOBEC3 genes in human populations have altered antiviral activity, we identified and functionally tested novel single nucleotide variants (SNVs) in APOBEC3 genes present in the 1000 Genome Project dataset. We found that common variants minor allele frequency (> 1%) of APOBEC3A, C, F, and G do not affect protein function. However, we found that two common novel polymorphisms in APOBEC3D decrease antiviral activity against HIV-1, and one polymorphism decreases activity against Alu retrotransposons. We characterized the diversity of APOBEC3 genes in three human populations and find significant evidence that APOBEC3D has evolved under purifying selection in recent human history. These data suggest that the activity of APOBEC3D has been maintained in human populations for a cellular function in host defense.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alu elements; Apobec3 locus; Apobec3D; Common polymorphisms; HIV; Human evolution

Mesh:

Substances:

Year:  2013        PMID: 23755966      PMCID: PMC3722276          DOI: 10.1016/j.virol.2013.05.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  APOBEC3 inhibits mouse mammary tumour virus replication in vivo.

Authors:  Chioma M Okeoma; Nika Lovsin; B Matija Peterlin; Susan R Ross
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

2.  DnaSP v5: a software for comprehensive analysis of DNA polymorphism data.

Authors:  P Librado; J Rozas
Journal:  Bioinformatics       Date:  2009-04-03       Impact factor: 6.937

3.  Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.

Authors:  Lindi Tan; Phuong Thi Nguyen Sarkis; Tao Wang; Chunjuan Tian; Xiao-Fang Yu
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

4.  The range of human APOBEC3H sensitivity to lentiviral Vif proteins.

Authors:  Melody M H Li; Lily I Wu; Michael Emerman
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.

Authors:  Ariana Harari; Marcel Ooms; Lubbertus C F Mulder; Viviana Simon
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

6.  Active Alu retrotransposons in the human genome.

Authors:  E Andrew Bennett; Heiko Keller; Ryan E Mills; Steffen Schmidt; John V Moran; Oliver Weichenrieder; Scott E Devine
Journal:  Genome Res       Date:  2008-10-03       Impact factor: 9.043

7.  Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Authors:  Fransje A Koning; Edmund N C Newman; Eun-Young Kim; Kevin J Kunstman; Steven M Wolinsky; Michael H Malim
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.

Authors:  Anna Maria Niewiadomska; Chunjuan Tian; Lindi Tan; Tao Wang; Phuong Thi Nguyen Sarkis; Xiao-Fang Yu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

9.  Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.

Authors:  Molly OhAinle; Julie A Kerns; Melody M H Li; Harmit S Malik; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

10.  Population stratification of a common APOBEC gene deletion polymorphism.

Authors:  Jeffrey M Kidd; Tera L Newman; Eray Tuzun; Rajinder Kaul; Evan E Eichler
Journal:  PLoS Genet       Date:  2007-04-20       Impact factor: 5.917

View more
  24 in total

1.  APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.

Authors:  John F Krisko; Nurjahan Begum; Caroline E Baker; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 2.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

3.  Identification of Owl Monkey CD4 Receptors Broadly Compatible with Early-Stage HIV-1 Isolates.

Authors:  Nicholas R Meyerson; Amit Sharma; Gregory K Wilkerson; Julie Overbaugh; Sara L Sawyer
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.

Authors:  Morgan E Meissner; Nora A Willkomm; Jamie Lucas; William G Arndt; Sarah F Aitken; Emily J Julik; Sunanda Baliga; Louis M Mansky
Journal:  J Mol Biol       Date:  2021-11-10       Impact factor: 5.469

5.  Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.

Authors:  Kavidha Reddy; Marcel Ooms; Michael Letko; Nigel Garrett; Viviana Simon; Thumbi Ndung'u
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

6.  Positive selection of primate genes that promote HIV-1 replication.

Authors:  Nicholas R Meyerson; Paul A Rowley; Christina H Swan; Dona T Le; Gregory K Wilkerson; Sara L Sawyer
Journal:  Virology       Date:  2014-03-21       Impact factor: 3.616

7.  HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.

Authors:  Jessica L Smith; Taisuke Izumi; Timothy C Borbet; Ariel N Hagedorn; Vinay K Pathak
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

Review 8.  APOBEC3 Proteins in Viral Immunity.

Authors:  Spyridon Stavrou; Susan R Ross
Journal:  J Immunol       Date:  2015-11-15       Impact factor: 5.422

9.  The Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from Monkeys.

Authors:  Lucie Etienne; Frederic Bibollet-Ruche; Peter H Sudmant; Lily I Wu; Beatrice H Hahn; Michael Emerman
Journal:  PLoS Pathog       Date:  2015-09-22       Impact factor: 6.823

10.  Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity.

Authors:  Eric W Refsland; Judd F Hultquist; Elizabeth M Luengas; Terumasa Ikeda; Nadine M Shaban; Emily K Law; William L Brown; Cavan Reilly; Michael Emerman; Reuben S Harris
Journal:  PLoS Genet       Date:  2014-11-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.